Evaluation of the Safety and Efficacy of Titanium-nitric Oxide-coated Stent (Optimax®) in Patients With Lesions With a Low Risk of Restenosis (Diameter ≥ 3.0 mm and Length ≤ 20 mm)

NCT03737565 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2025-06-15

No results posted yet for this study

Summary

This prospective registry is intended to evaluate the safety and efficacy of the Optimax® stent.

Conditions

Interventions

DEVICE

Optimax stent®

Percutaneous coronary intervention with Optimax stent®

Sponsors & Collaborators

  • Fundación EPIC

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-17
Primary Completion
2025-01-02
Completion
2025-01-02

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03737565 on ClinicalTrials.gov